Self-management with verapamil or metoprolol for paroxysmal atrial fibrillation
Treatments studied
Part of Heart & circulation clinical trials.
This trial compares two medications that control heart rate, verapamil and metoprolol, taken only when you feel an episode of paroxysmal atrial fibrillation (short, irregular heartbeats). It also tests a smartphone app that helps you manage your condition. The goal is to see if this approach improves symptoms and reduces episodes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with paroxysmal atrial fibrillation (AF) based on an ECG test.
- You have had at least 2 episodes of AF symptoms in the last 4 months that stopped on their own.
- You are willing and able to give informed consent to participate.
- For the smartphone sub-study: you need to own a smartphone.
- You must not have certain heart conditions or other health issues that would make the study drugs unsafe (your doctor will check this).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a mobile education program on a smartphone to help you learn about and manage your atrial fibrillation. If found helpful, it could improve your symptoms and quality of life.
This study tests a new medication, AP31969, to control heart rhythm in people with atrial fibrillation. It compares the drug to a placebo to see if it can reduce how often AF episodes happen over time.
This study compares two medications, verapamil and metoprolol, given in the emergency department to slow down a fast, irregular heartbeat caused by atrial fibrillation. It aims to find which medicine works better and is safer for patients like you.
This study tests whether using a smartwatch to track how much time your heart is in AFib each day can help guide treatment. It aims to see if keeping AFib episodes low leads to better outcomes.
This study tests whether a smartphone app (FibriCheck) can accurately track heart rhythm recovery after a cardioversion procedure. If you join, you will use the app at home to measure your heart rhythm, which may reduce the need for frequent clinic visits.
This trial studies whether sending heart rhythm recordings from a phone (using the KardiaMobile ECG device) can improve health care use and patient experience for people with atrial fibrillation. It may help your care team monitor you more smoothly—if you meet the study requirements.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.